Nasal polyps in the real world: a China registry study
Part of Ear, nose & throat, Lungs & breathing clinical trials.
This study tracks people with chronic sinusitis and nasal polyps over time to learn how the condition affects them and how treatments work in everyday life. It is an observational registry, so participants receive their usual care while providing data to help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 years or older.
- You have been diagnosed with chronic sinusitis and have nasal polyps in both nostrils.
- Your nasal polyps are moderate to severe, based on a doctor's exam.
- You have had nasal congestion and/or loss of smell for at least the past 2 weeks.
- You can commit to attending follow-up visits and providing information over time.
- If you are under 18, a parent or guardian must agree in writing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for markers in the blood that can predict how well certain biologic drugs work for people with chronic sinusitis and nasal polyps. It may help find the right treatment for you if your symptoms are not controlled with standard sprays or after surgery.
This study examines the type of inflammation in nasal polyps by collecting small tissue samples during surgery. It may help doctors better understand why some people develop nasal polyps and how to treat them more effectively.
This trial tests an injectable drug called TQC2731 for people with chronic sinusitis and nasal polyps that haven't been controlled well enough by standard treatments like steroid sprays or surgery. The goal is to see if it helps reduce nasal congestion, improve sense of smell, and shrink polyps.
This trial tests an investigational medication called AK139 for people with chronic sinusitis and nasal polyps. The treatment aims to reduce nasal congestion and polyp size, potentially improving symptoms.
This study follows people with chronic rhinosinusitis and nasal polyps who are starting a biologic medication (omalizumab, mepolizumab, or dupilumab) to see how well it works in real life.
This study looks at the connection between your nasal microbiome (the tiny living things in your nose) and severe nasal polyps caused by type 2 inflammation. It may help find new ways to treat chronic sinusitis with polyps.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.